Skip to main content
Premium Trial:

Request an Annual Quote

Bayer HealthCare Licenses Genomatix ChipInspector Array-Analysis Tool

NEW YORK, May 22 (GenomeWeb News) - Bayer HealthCare has licensed Genomatix's ChipInspector microarray analysis tool , Genomatix said today.

 

Scientists at the drug maker will use ChipInspector to analyze raw data from Affymetrix GeneChip and Exon arrays. The platform uses a single probe approach based on Genomatix's ElDorado annotation pipeline, according the company said. The annotation drive platform integrates literature and pathway mining in one system.

 

Financial details of the deal were not disclosed.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.